Not so fast: adaptive suppression of innate immunity.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Type 2 Diabetes Mellitus and COVID-19: A Narrative Review.Frontiers in endocrinology · 2021
   Pooled it
2. Succinate in innate immunity: linking metabolic reprogramming to immune modulation.Frontiers in immunology · 2025
   Review
3. Identification of KeyInternational journal of molecular sciences · 2023
   Article
4. T-cell immunity to SARS-CoV-2: what if the known best is not the optimal course for the long run? Adapting to evolving targets.Frontiers in immunology · 2023
   Review
5. Characterization of regulatory T cells in SARS-CoV-2 infected hemodialysis patients: relation to clinical and radiological severity.BMC nephrology · 2022
   Article
6. COVID-19: imbalanced cell-mediated immune response drives to immunopathology.Emerging microbes & infections · 2022
   Review
7. Hyperglycemia and Hypoglycemia Are Associated with In-Hospital Mortality among Patients with Coronavirus Disease 2019 Supported with Extracorporeal Membrane Oxygenation.Journal of clinical medicine · 2022
   Article
8. COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
   Review
9. An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19).Cellular & molecular biology letters · 2022
   Review
10. Differences in peripheral immune system gene expression in frontotemporal degeneration.Medicine · 2022
    Article
11. Innate Immunity as an Executor of the Programmed Death of Individual Organisms for the Benefit of the Entire Population.International journal of molecular sciences · 2021
    Review
12. Antigenic sites in SARS-CoV-2 spike RBD show molecular similarity with pathogenic antigenic determinants and harbors peptides for vaccine development.Immunobiology · 2021
    Article
13. The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients.Nature communications · 2021
    Article
14. Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021
    Review
15. Human Coronaviruses: Counteracting the Damage by Storm.Viruses · 2021
    Review
16. Aging-induced fragility of the immune system.Journal of theoretical biology · 2021
    Article
17. COVID-19 and diabetes; Possible role of polymorphism and rise of telemedicine.Primary care diabetes · 2021
    Review
18. Why COVID-19 is less frequent and severe in children: a narrative review.World journal of pediatrics : WJP · 2021
    Review
19. Diabetes and COVID-19.Open life sciences · 2021
    Review
20. T Cells: Warriors of SARS-CoV-2 Infection.Trends in immunology · 2021
    Review

Corrections and comments

• Comment on
  Adaptive immune cells temper initial innate responses.2007

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as